Literature DB >> 28576596

Bronchoalveolar lavage triacetylfusarinine C (TAFC) determination for diagnosis of invasive pulmonary aspergillosis in patients with hematological malignancies.

Thomas Orasch1, Juergen Prattes2, Klaus Faserl3, Susanne Eigl4, Wiebke Düttmann5, Herbert Lindner3, Hubertus Haas6, Martin Hoenigl7.   

Abstract

Entities:  

Keywords:  Antifungal prophylaxis; Antimould treatment; Galactomannan; Lateral flow device; Siderophores

Mesh：

Substances：

Year:  2017        PMID： 28576596      PMCID： PMC5757784          DOI： 10.1016/j.jinf.2017.05.014

Source DB:  PubMed          Journal:  J Infect        ISSN： 0163-4453            Impact factor:   6.072


× No keyword cloud information.
  10 in total

1.  Bronchoalveolar lavage lateral-flow device test for invasive pulmonary aspergillosis diagnosis in haematological malignancy and solid organ transplant patients.

Authors:  Martin Hoenigl; Christoph Koidl; Wiebke Duettmann; Katharina Seeber; Jasmin Wagner; Walter Buzina; Albert Wölfler; Reinhard B Raggam; Christopher R Thornton; Robert Krause
Journal:  J Infect       Date:  2012-10-15       Impact factor: 6.072

2.  Galactomannan testing and Aspergillus PCR in same-day bronchoalveolar lavage and blood samples for diagnosis of invasive aspergillosis.

Authors:  Susanne Eigl; Martin Hoenigl; Birgit Spiess; Sven Heldt; Juergen Prattes; Peter Neumeister; Albert Wolfler; Jasmin Rabensteiner; Florian Prueller; Robert Krause; Mark Reinwald; Holger Flick; Dieter Buchheidt; Tobias Boch
Journal:  Med Mycol       Date:  2017-07-01       Impact factor: 4.076

3.  Diagnostic accuracy of the Aspergillus-specific bronchoalveolar lavage lateral-flow assay in haematological malignancy patients.

Authors:  Juergen Prattes; Michaela Lackner; Susanne Eigl; Frederike Reischies; Reinhard B Raggam; Christoph Koidl; Holger Flick; Robert Wurm; Michael Palfner; Albert Wölfler; Peter Neumeister; Christopher R Thornton; Robert Krause; Cornelia Lass-Flörl; Martin Hoenigl
Journal:  Mycoses       Date:  2015-06-23       Impact factor: 4.377

4.  Performance of galactomannan, beta-d-glucan, Aspergillus lateral-flow device, conventional culture, and PCR tests with bronchoalveolar lavage fluid for diagnosis of invasive pulmonary aspergillosis.

Authors:  M Hoenigl; J Prattes; B Spiess; J Wagner; F Prueller; R B Raggam; V Posch; W Duettmann; K Hoenigl; A Wölfler; C Koidl; W Buzina; M Reinwald; C R Thornton; R Krause; D Buchheidt
Journal:  J Clin Microbiol       Date:  2014-03-26       Impact factor: 5.948

5.  Influence of mould-active antifungal treatment on the performance of the Aspergillus-specific bronchoalveolar lavage fluid lateral-flow device test.

Authors:  Susanne Eigl; Juergen Prattes; Mark Reinwald; Christopher R Thornton; Frederike Reischies; Birgit Spiess; Peter Neumeister; Ines Zollner-Schwetz; Reinhard B Raggam; Holger Flick; Dieter Buchheidt; Robert Krause; Martin Hoenigl
Journal:  Int J Antimicrob Agents       Date:  2015-06-30       Impact factor: 5.283

6.  Galactomannan in bronchoalveolar lavage fluid for diagnosis of invasive aspergillosis in non-hematological patients.

Authors:  J Fortún; P Martín-Dávila; E Gomez Garcia de la Pedrosa; J T Silva; J Garcia-Rodríguez; D Benito; E Venanzi; F Castaño; M Fernández-Ruiz; F Lazaro; R García-Luján; I Quiles; J J Cabanillas; S Moreno; J M Aguado
Journal:  J Infect       Date:  2016-03-26       Impact factor: 6.072

7.  Revised definitions of invasive fungal disease from the European Organization for Research and Treatment of Cancer/Invasive Fungal Infections Cooperative Group and the National Institute of Allergy and Infectious Diseases Mycoses Study Group (EORTC/MSG) Consensus Group.

Authors:  Ben De Pauw; Thomas J Walsh; J Peter Donnelly; David A Stevens; John E Edwards; Thierry Calandra; Peter G Pappas; Johan Maertens; Olivier Lortholary; Carol A Kauffman; David W Denning; Thomas F Patterson; Georg Maschmeyer; Jacques Bille; William E Dismukes; Raoul Herbrecht; William W Hope; Christopher C Kibbler; Bart Jan Kullberg; Kieren A Marr; Patricia Muñoz; Frank C Odds; John R Perfect; Angela Restrepo; Markus Ruhnke; Brahm H Segal; Jack D Sobel; Tania C Sorrell; Claudio Viscoli; John R Wingard; Theoklis Zaoutis; John E Bennett
Journal:  Clin Infect Dis       Date:  2008-06-15       Impact factor: 9.079

8.  Iron - A Key Nexus in the Virulence of Aspergillus fumigatus.

Authors:  Hubertus Haas
Journal:  Front Microbiol       Date:  2012-02-06       Impact factor: 5.640

9.  An iron-mimicking, Trojan horse-entering fungi--has the time come for molecular imaging of fungal infections?

Authors:  Hubertus Haas; Milos Petrik; Clemens Decristoforo
Journal:  PLoS Pathog       Date:  2015-01-29       Impact factor: 6.823

10.  Detection of a Serum Siderophore by LC-MS/MS as a Potential Biomarker of Invasive Aspergillosis.

Authors:  Cassandra S Carroll; Lawrence N Amankwa; Linda J Pinto; Jeffrey D Fuller; Margo M Moore
Journal:  PLoS One       Date:  2016-03-14       Impact factor: 3.240
  10 in total
  9 in total

Review 1.  Aspergillus fumigatus and aspergillosis: From basics to clinics.

Authors:  A Arastehfar; A Carvalho; J Houbraken; L Lombardi; R Garcia-Rubio; J D Jenks; O Rivero-Menendez; R Aljohani; I D Jacobsen; J Berman; N Osherov; M T Hedayati; M Ilkit; D James-Armstrong; T Gabaldón; J Meletiadis; M Kostrzewa; W Pan; C Lass-Flörl; D S Perlin; M Hoenigl
Journal:  Stud Mycol       Date:  2021-05-10       Impact factor: 16.097

Review 2.  [Aspergillus in airway material : Ignore or treat?]

Authors:  H J F Salzer; C Lange; M Hönigl
Journal:  Internist (Berl)       Date:  2017-11       Impact factor: 0.743

3.  Diagnosis of invasive aspergillosis in hematological malignancy patients: Performance of cytokines, Asp LFD, and Aspergillus PCR in same day blood and bronchoalveolar lavage samples.

Authors:  Sven Heldt; Juergen Prattes; Susanne Eigl; Birgit Spiess; Holger Flick; Jasmin Rabensteiner; Gemma Johnson; Florian Prüller; Albert Wölfler; Tobias Niedrist; Tobias Boch; Peter Neumeister; Heimo Strohmaier; Robert Krause; Dieter Buchheidt; Martin Hoenigl
Journal:  J Infect       Date:  2018-07-01       Impact factor: 6.072

4.  Triacetylfusarinine C: A urine biomarker for diagnosis of invasive aspergillosis.

Authors:  Martin Hoenigl; Thomas Orasch; Klaus Faserl; Juergen Prattes; Juergen Loeffler; Jan Springer; Fabio Gsaller; Frederike Reischies; Wiebke Duettmann; Reinhard B Raggam; Herbert Lindner; Hubertus Haas
Journal:  J Infect       Date:  2018-09-26       Impact factor: 6.072

Review 5.  Treatment of Aspergillosis.

Authors:  Jeffrey D Jenks; Martin Hoenigl
Journal:  J Fungi (Basel)       Date:  2018-08-19

6.  Existing tests vs. novel non-invasive assays for detection of invasive aspergillosis in patients with respiratory diseases.

Authors:  Wei Xiao; Longyi Du; Linli Cai; Tiwei Miao; Bing Mao; Fuqiang Wen; Peter Gerard Gibson; Deying Gong; Yan Zeng; Mei Kang; Xinmiao Du; Junyan Qu; Yan Wang; Xuemei Liu; Ruizhi Feng; Juanjuan Fu
Journal:  Chin Med J (Engl)       Date:  2022-07-25       Impact factor: 6.133

Review 7.  Spotlight on isavuconazole in the treatment of invasive aspergillosis and mucormycosis: design, development, and place in therapy.

Authors:  Jeffrey D Jenks; Helmut Jf Salzer; Juergen Prattes; Robert Krause; Dieter Buchheidt; Martin Hoenigl
Journal:  Drug Des Devel Ther       Date:  2018-04-30       Impact factor: 4.162

Review 8.  Current State of the Diagnosis of Invasive Pulmonary Aspergillosis in Lung Transplantation.

Authors:  Sabina Herrera; Shahid Husain
Journal:  Front Microbiol       Date:  2019-01-09       Impact factor: 5.640

9.  Diagnosis of Breakthrough Fungal Infections in the Clinical Mycology Laboratory: An ECMM Consensus Statement.

Authors:  Jeffrey D Jenks; Jean-Pierre Gangneux; Ilan S Schwartz; Ana Alastruey-Izquierdo; Katrien Lagrou; George R Thompson Iii; Cornelia Lass-Flörl; Martin Hoenigl
Journal:  J Fungi (Basel)       Date:  2020-10-11
  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.